Covered recipient · General Payments record
BENAN BARAKAT
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2022–2024
$1,580.60
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $745.29 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $172.78 | 2 |
| EMD Serono, Inc. | $144.78 | 6 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $125.35 | 1 |
| Amylyx Pharmaceuticals, Inc. | $121.22 | 1 |
| ARGENX US, INC. | $119.94 | 1 |
| Lilly USA, LLC | $23.20 | 1 |
| PFIZER INC. | $19.11 | 1 |
| TG THERAPEUTICS, INC. | $18.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $92.83 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277091 | CMS |
| ABBVIE INC. | $79.95 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277093 | CMS |
| Amylyx Pharmaceuticals, Inc. | $121.22 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148254055 | CMS |
| ARGENX US, INC. | $119.94 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142151340 | CMS |
| EMD Serono, Inc. | $24.18 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120240136 | CMS |
| EMD Serono, Inc. | $28.80 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120248477 | CMS |
| EMD Serono, Inc. | $32.70 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120217542 | CMS |
| EMD Serono, Inc. | $6.88 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120259030 | CMS |
| EMD Serono, Inc. | $30.48 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120259034 | CMS |
| EMD Serono, Inc. | $21.74 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120269314 | CMS |
| Lilly USA, LLC | $23.20 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136060894 | CMS |
| Novartis Pharmaceuticals Corporation | $125.35 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086666675 | CMS |
| PFIZER INC. | $19.11 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132117696 | CMS |
| TG Therapeutics, Inc. | $18.91 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136881139 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.